Creative Planning - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 33 filers reported holding AGEX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$48,212
-24.3%
70,900
-0.6%
0.00%
Q2 2023$63,730
+32.8%
71,350
-1.4%
0.00%
Q1 2023$47,975
+20.1%
72,3600.0%0.00%
Q4 2022$39,935
-2.6%
72,3600.0%0.00%
Q3 2022$41,000
-2.4%
72,3600.0%0.00%
Q2 2022$42,000
-6.7%
72,360
+38.2%
0.00%
Q1 2022$45,000
+28.6%
52,360
+62.8%
0.00%
Q4 2021$35,000
+16.7%
32,160
+1.6%
0.00%
Q3 2021$30,000
-36.2%
31,660
+3.7%
0.00%
Q2 2021$47,000
-6.0%
30,540
-0.4%
0.00%
Q1 2021$50,00030,6730.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 2,997,156$1,654,1300.14%
Strategic Wealth Investment Group, LLC 86,440$60,5160.01%
Prescott General Partners LLC 185,185$102,2040.01%
Summit X, LLC 33,000$19,0150.01%
Beirne Wealth Consulting Services, LLC 18,000$9,9340.01%
Sigma Planning Corp 134,977$74,4940.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 169,770$93,6960.00%
UBS Group AG 13,502$7,4260.00%
NewEdge Advisors, LLC 1$00.00%
BNP PARIBAS FINANCIAL MARKETS 334$1840.00%
View complete list of AGEX THERAPEUTICS INC shareholders